New York Ventures
CVC
Active
New York, United States
110
4M
60
4
0.45
1
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the New York Ventures, startups are often financed by RRE Ventures, Cayuga Venture Fund, Scout Ventures. The meaningful sponsors for the fund in investment in the same round are Scout Ventures, Alexandria Venture Investments, u2i. In the next rounds fund is usually obtained by Town Hall Ventures, Tom Golisano, Scout Ventures.
The top activity for fund was in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Quentis Therapeutics, Kinvolved, MouSensor Among the most popular fund investment industries, there are Software, Health Care. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 110
- Lead investments
- 4
- Exits
- 1
- Follow on index
- 0.45
- Investments by industry
- Health Care (31)
- Biotechnology (22)
- Software (16)
- Medical (16)
- Artificial Intelligence (11) Show 114 more
- Investments by region
-
- United States (106)
- Canada (1)
- Israel (3)
- Peak activity year
- 2022
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 25M
- Group Appearance index
- 0.35
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| TARA Biosystems | 01 May 2019 | Biotechnology, Medical | Early Stage Venture | United States, New York, New York | |
| ZeroMark | 24 May 2024 | Government, Artificial Intelligence, Robotics, National Security, Augmented Reality, Law Enforcement | Seed | 7M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.